2019
DOI: 10.1016/j.joca.2019.07.011
|View full text |Cite
|
Sign up to set email alerts
|

The importance of getting it right the first time

Abstract: TLNJ is supported by unrestricted academic grants from the Sigrid Juselius Foundation, the State funding for university-level health research (Helsinki University Hospital), the Social Insurance Institution of Finland (KELA), and the Academy of Finland. These organizations had no involvement in the writing of the manuscript or its intellectual content.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
(15 reference statements)
0
2
0
Order By: Relevance
“…Thus, preclinical screening could help to ensure that these patients can be stratified for alternative therapeutic interventions more quickly to prevent the worsening of symptoms and osteoarthritis (OA) progression, in line with the ''getting it right first time'' scheme. 18 We previously demonstrated that protein differences exist within the synovial fluid of those who either show clinical improvement after ACI (responders) or not (nonresponders). 11,12,34 Despite this, there remains a need to identify biomarkers that have the capacity to predict clinical outcome after ACI and other orthopaedic interventions and can be detected within the blood.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, preclinical screening could help to ensure that these patients can be stratified for alternative therapeutic interventions more quickly to prevent the worsening of symptoms and osteoarthritis (OA) progression, in line with the ''getting it right first time'' scheme. 18 We previously demonstrated that protein differences exist within the synovial fluid of those who either show clinical improvement after ACI (responders) or not (nonresponders). 11,12,34 Despite this, there remains a need to identify biomarkers that have the capacity to predict clinical outcome after ACI and other orthopaedic interventions and can be detected within the blood.…”
mentioning
confidence: 99%
“…Thus, preclinical screening could help to ensure that these patients can be stratified for alternative therapeutic interventions more quickly to prevent the worsening of symptoms and osteoarthritis (OA) progression, in line with the “getting it right first time” scheme. 18 …”
mentioning
confidence: 99%